Search


Start a new search
Add filters:

Use filters to refine the search results.


Results 771-780 of 875
Item hits:
Issue DateTitleAuthor(s)
17-Feb-2009Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancerSharma, R; Graham, J; Mitchell, H; Brooks, A; Blagden, S, et al
1-Sep-2010The RNA binding protein Larp1 regulates cell division, apoptosis and cell migrationBurrows, C; Latip, NA; Lam, S-J; Carpenter, L; Sawicka, K, et al
2-Oct-2001A prognostic model for ovarian cancerClark, TG; Stewart, ME; Altman, DG; Gabra, H; Smyth, JF
9-Aug-2012Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancerHarding, V; Fenu, E; Medani, H; Shaboodien, R; Ngan, S, et al
28-Jun-2019Wnt-11 as a potential prognostic biomarker and therapeutic target in colorectal cancerGorroño-Etxebarria, I; Aguirre, U; Sanchez, S; González, N; Escobar, A, et al
1-Jan-2019Circulating tumour cells and cell-free DNA in pancreatic ductal adenocarcinomaGall, TM; Belete, S; Khanderia, E; Frampton, AE; Jiao, LR, et al
11-Jul-2011Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancerSharma, R; Graham, J; Blagden, S; Gabra, H
1-Dec-2018Clinical translation of [F-18]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancerDubash, SR; Merchant, S; Heinzmann, K; Mauri, F; Lavdas, I, et al
1-Dec-2014Introduction to managing patients with recurrent ovarian cancerGabra, H
-Targeting AREG derived from senescent stromal cells diminishes cancer resistance and averts PD-L1-mediated immunosuppressionXu, Q; Long, Q; Zhu, D; Fu, D; Zhang, B, et al